Description
An FXR receptor antagonist (IC50 = 40 µM); a taurine-conjugated form of the murine-specific primary bile acid β-muricholic acid; is reduced in mice after colonization with feces from a human donor; increased in the intestines of mice resistant to high-fat diet-induced obesity, fatty liver, and diabetes
Formal name: 2-[[(3α,5β,6β,7β)-3,6,7-trihydroxy-24-oxocholan-24-yl]amino]-ethanesulfonic acid, monosodium salt
Synonyms: Tauro-β-muricholate|TβMCA
Molecular weight: 537.7
CAS: 145022-92-0
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Endocrinology & Metabolism|Bile Acids & Microbiome||Research Area|Endocrinology & Metabolism|Hormones & Receptors|FXRs & LXRs||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|NAFLD & NASH||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity